Procurement Of Brexucabtagene Autoleucelle (Tecartus® 0.4 – 2 × 108 Cells Infusion Solution, Dispersion)

  Address - Finland

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 99152540

  Document Type - Tender Notices

Description - Description: Procurement of brexucabtagene autoleucelle (Tecartus ® 0.4 -2 × 108 cells infusion solution, dispersion) for use in accordance with the summary of product characteristics and the recommendations of the Finnish Health Care Service Selec tion Council (Palko) (15 December 2021 and 7 November 2024) in adults with relapsed or refractory mantle cell lymphoma who have been treated with at least two prior lines of therapy, including treatment with a Bruton's tyrosine kinase (BTK) inhibitor, and in patients aged 26 years or older in good health (ECOG performance status 0-1) for the treatment of relapsed or refractory precursor B-cell acute lymphoblastic leukemia (ALL).local title:: Brek

Gt Ref Id - 99152540

Deadline - Dec 20, 2024